PT  - JOURNAL ARTICLE
AU  - Ho, Shannon J.
AU  - Chaput, Dale
AU  - Sinkey, Rachel G.
AU  - Garces, Amanda H.
AU  - New, Erika P.
AU  - Okuka, Maja
AU  - Sang, Peng
AU  - Arlier, Sefa
AU  - Semerci, Nihan
AU  - Steffensen, Thora S.
AU  - Rutherford, Thomas J.
AU  - Alsina, Angel E.
AU  - Cai, Jianfeng
AU  - Anderson, Matthew L.
AU  - Magness, Ronald R.
AU  - Uversky, Vladimir N.
AU  - Cummings, Derek A. T.
AU  - Tsibris, John C. M.
TI  - Proteomic studies of human placentas reveal partnerships associated with preeclampsia, diabetes, gravidity, and labor
AID  - 10.1101/2023.07.23.23292673
DP  - 2023 Jan 01
TA  - medRxiv
PG  - 2023.07.23.23292673
4099  - http://medrxiv.org/content/early/2023/07/27/2023.07.23.23292673.short
4100  - http://medrxiv.org/content/early/2023/07/27/2023.07.23.23292673.full
AB  - VEGFR2 is a central regulator of placental angiogenesis. The study of the VEGFR2 proteome of chorionic villi at term revealed its partners MDMX and PICALM. The oxytocin receptor (OT-R) and vasopressin V1aR receptor were detected in MDMX and PICALM immunoprecipitations. Immunogold electron microscopy showed VEGFR2 on endothelial cell (EC) nuclei, mitochondria, and Hofbauer cells (HC), the tissue-resident macrophages. MDMX, PICALM, and V1aR were on EC plasma membranes, nuclei, and HC nuclei. Unexpectedly, PICALM and OT-R were detected on EC projections into the fetal lumen and OT-R on 20-150 nm clusters therein, prompting the hypothesis that placental exosomes transport OT-R to the fetus and across the blood-brain barrier. Insights on gestational complications were gained by univariable and multivariable regression analyses associating preeclampsia with lower MDMX protein levels in membrane extracts of chorionic villi, and lower MDMX, PICALM, OT-R, and V1aR with spontaneous vaginal deliveries compared to cesarean deliveries before labor. We found select associations between higher MDMX, PICALM, OT-R and either gravidity, diabetes, BMI, maternal age, or neonatal weight, and correlations between PICALM-OT-R (p<2.7x10-8), PICALM-V1aR (p<0.006), and OT-R-V1aR (p<0.001). These results offer for exploration new partnerships in metabolic networks, tissue-resident immunity, and labor, notably for HC that predominantly express MDMX.Competing Interest StatementDATC declares a grant from Merck for research unrelated to this manuscript. The remaining authors declare no competing interests.Funding StatementThis study was supported by the Department of Obstetrics and Gynecology at the University of South Florida and research funds from Tampa General Hospital (AEA) and the Teasley Foundation (TJR).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Research Integrity and Compliance, University of South Florida, Tampa, FL. IRB-approved study protocol Pro00015578, John Tsibris PI.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesThe video of the chorionic villi is deposited at https://nam04.safelinks.protection.outlook.com/?url=https%3A%2F%2Fzenodo.org%2Frecord%2F8160169%3Ftoken%3DeyJhbGciOiJIUzUxMiIsImV4cCI6MTY5MjMwOTU5OSwiaWF0IjoxNjg5Njk3NDQzfQ.eyJkYXRhIjp7InJlY2lkIjo4MTYwMTY5fSwiaWQiOjM1ODEzLCJybmQiOiJjMTlkOTM2NCJ9.2OSYKMRxBpqO7afBKem_S8HdQJgmbtnahLFTgJ_5hoiK3wxcbB2fvuyqEPJ0PeTtF_r9f9Zuocr6LcfXPs2-gw&data=05%7C01%7Ctsibris%40usf.edu%7C02564875fb61480dab4f08db87ae6fdb%7C741bf7dee2e546df8d6782607df9deaa%7C0%7C0%7C638252955485880125%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&sdata=iukZjlFOvoIiQAdfd566alnMH33jLMz3TV%2BDqPv5Trk%3D&reserved=0.All MS raw files and corresponding results files will be deposited to the ProteomeXchange Consortium via the PRIDE partner repository.